The novel and selective insulin-like growth factor-1 receptor kinase inhibitor PQIP suppresses bone cell function and osteoclast-breast cancer cell cross-talk in vitro

Bone ◽  
2011 ◽  
Vol 48 (1) ◽  
pp. S43
Author(s):  
J.G. Logan* ◽  
E. Landao-Bassonga ◽  
V.G. Brunton ◽  
A.I. Idris
Keyword(s):  
Breast Cancer ◽  
Growth Factor ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Cell Function ◽  
Kinase Inhibitor ◽  
Bone Cell ◽  
The Novel ◽  
Receptor Kinase

scholarly journals Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro

Diabetologia ◽  
2012 ◽  
Vol 55 (10) ◽  
pp. 2811-2822 ◽  
Author(s):  
V. D’Esposito ◽  
F. Passaretti ◽  
A. Hammarstedt ◽  
D. Liguoro ◽  
D. Terracciano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Fatty Acids ◽  
Growth Factor ◽  
Cell Growth ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Insulin Like Growth Factor ◽  
Cancer Cell Growth ◽  
Breast Cancer Cell Growth

Direct effect of sevoflurane on breast cancer cell function in vitro

2010 ◽  
Vol 27 ◽  
pp. 1
Author(s):  
P. Ecimovic ◽  
B. McHugh ◽  
D. Murray ◽  
P. Doran ◽  
D. Buggy
Keyword(s):  
Breast Cancer ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Direct Effect ◽  
Cell Function

scholarly journals Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro †

2009 ◽  
Vol 103 (5) ◽  
pp. 685-690 ◽  
Author(s):  
C.A. Deegan ◽  
D. Murray ◽  
P. Doran ◽  
P. Ecimovic ◽  
D.C. Moriarty ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Oestrogen Receptor ◽  
Cell Function ◽  
Anaesthetic Technique

scholarly journals Direct effect of morphine on breast cancer cell function in vitro : role of the NET1 gene

2011 ◽  
Vol 107 (6) ◽  
pp. 916-923 ◽  
Author(s):  
P. Ecimovic ◽  
D. Murray ◽  
P. Doran ◽  
J. McDonald ◽  
D.G. Lambert ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Direct Effect ◽  
Cell Function

Xenon and breast cancer cell function in-vitro

2014 ◽  
Vol 31 ◽  
pp. 160
Author(s):  
S. A. Ash ◽  
G. Valchev ◽  
P. Crowley ◽  
H. G. Gallagher ◽  
D. J. Buggy
Keyword(s):  
Breast Cancer ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Cell Function

ANTITUMOR EFFECT OF SUNITINIB AND BORTEZOMIB ON BREAST CANCER CELL LINE IN VITRO

2017 ◽  
Vol 63 (1) ◽  
pp. 141-145
Author(s):  
Yuliya Khochenkova ◽  
Eliso Solomko ◽  
Oksana Ryabaya ◽  
Yevgeniya Stepanova ◽  
Dmitriy Khochenkov
Keyword(s):  
Breast Cancer ◽  
Cell Line ◽  
Cell Lines ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Antitumor Effect ◽  
Cancer Cell Lines ◽  
Breast Cancer Cell Lines ◽  
Actual Problem

The discovery for effective combinations of anticancer drugs for treatment for breast cancer is the actual problem in the experimental chemotherapy. In this paper we conducted a study of antitumor effect of the combination of sunitinib and bortezomib against MDA-MB-231 and SKBR-3 breast cancer cell lines in vitro. We found that bortezomib in non-toxic concentrations can potentiate the antitumor activity of sunitinib. MDA-MB-231 cell line has showed great sensitivity to the combination of bortezomib and sunitinib in vitro. Bortezomib and sunitinib caused reduced expression of receptor tyrosine kinases VEGFR1, VEGFR2, PDGFRa, PDGFRß and c-Kit on HER2- and HER2+ breast cancer cell lines

Sign in / Sign up

Export Citation Format

Share Document